Radiation Oncology Patient Medical Physics Intervention Study
Lay Description
This investigation is designed to be a two-arm, non-randomized prospective phase 2 study evaluating the impact of medical physicist patient intervention on the anxiety level and patient satisfaction of patients undergoing a course of radiation therapy. Our goal is to demonstrate that these interventions will have a significantly positive impact on the overall well-being of our oncology patients
Category
- Cancers and Other Neoplasms
- Other Respiratory and Intrathoracic Organs
- IRB Number
- 20200061HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Between 18 and 0
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Patients receiving treatment in the outpatient setting.
Patients with an Eastern Cooperative Oncology Group Performance Status (ECOG PS) 0, 1, or 2.
Exclusion Criteria
Patients receiving a single fraction of treatment.
???????History of Prior Radiation.
Study Design
Arm Groups
Study Contact
Regulatory Point of Contact
Frances Crawford
(210) 450-5037
crawfordf1@uthscsa.edu
Regulatory Point of Contact
Sonia Creighton
(210) 450-1366
creighton@uthscsa.edu
Regulatory Point of Contact
Myrna Montenegro
(210) 450-5954
montenegro@uthscsa.edu
Regulatory Point of Contact
Mailbox Ctrc Regulatory Affairs
regaffapp@uthscsa.edu
Regulatory Point of Contact
Regulatory Staff
regaffstaff@uthscsa.edu
Regulatory Point of Contact
Kathleen Rodriguez
(210) 450-1365
rodriguezk3@uthscsa.edu
Regulatory Point of Contact
Pia Ashley Roperes
(210) 450-1794
roperes@uthscsa.edu
Regulatory Point of Contact
Benjamin Schleif
(210) 450-1366
schleifb@uthscsa.edu
Regulatory Point of Contact
Morgan Seekatz
(210) 450-1133
seekatz@uthscsa.edu
Regulatory Point of Contact
Timothy Wagner
(210) 450-6496
wagnert@uthscsa.edu
Overall Recruitment Point of Contact
Timothy Wagner
(210) 450-6496
wagnert@uthscsa.edu
Principal Investigator
Timothy Wagner